1. Ganetespib, an HSP90 inhibitor, kills Epstein–Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood. Issue 4 (3rd April 2017) Authors: Shatzer, Amber; Ali, Mir A.; Chavez, Mayra; Dowdell, Kennichi; Lee, Min-Jung; Tomita, Yusuke; El-Hariry, Iman; Trepel, Jane B.; Proia, David A.; Cohen, Jeffrey I. Journal: Leukemia & lymphoma Issue: Volume 58:Issue 4(2017) Page Start: 923 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗